+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

In Vitro Diagnostics Market Report 2024-2034

  • PDF Icon

    Report

  • 367 Pages
  • October 2024
  • Region: Global
  • Visiongain
  • ID: 6010612
Description Jump to:
Overall world revenue for the In Vitro Diagnostics Market: In terms of value the market will surpass US$100 billion in 2024, the work calculates. The publisher predicts strong revenue growth through to 2034. The work identifies which organizations hold the greatest potential. Discover their capabilities, progress, and commercial prospects, helping you stay ahead.

The In Vitro Diagnostics Market Report 2024-2034: This report will prove invaluable to leading firms striving for new revenue pockets if they wish to better understand the industry and its underlying dynamics. It will be useful for companies that would like to expand into different industries or to expand their existing operations in a new region.

Technological Advancements Propelling Industry Growth

The surge in precision, portability, and affordability of diagnostic technologies is significantly driving growth in the market. The global adoption of innovative in-vitro diagnostic (IVD) tests is gaining momentum, fuelled by the introduction of advanced and highly accurate clinical laboratory tests. For instance, in June 2023, Japan's Ministry of Health, Labour, and Welfare granted approval for Toray Industries, Inc.'s Toray APOA2-iTQ, a diagnostic tool for pancreatic cancer. Likewise, in March 2023, the U.S. FDA approved Abbott's pioneering blood test for Traumatic Brain Injury (TBI). The successful approval and deployment of such cutting-edge IVD tests for critical health conditions are poised to unlock substantial commercial opportunities, positioning companies at the forefront of this evolving landscape. This trend underscores the importance of investing in research and development to remain competitive and responsive to emerging healthcare needs.

Segment Analysis

In 2024, the reagents segment is projected to hold over 50% of the market share, and is expected to maintain its dominance with the highest compound annual growth rate (CAGR) projected from 2024 to 2034. This growth trajectory is driven by extensive research and development initiatives undertaken by major industry players to innovate novel reagents and diagnostic kits. A noteworthy example is BD's market authorization in February 2023 for the BD Onclarity HPV Assay, which is used in conjunction with the ThinPrep Pap Test in the United States. Such advancements underscore the increasing emphasis on research and development aimed at enhancing rapid cancer diagnostics and precision medicine solutions, allowing companies to capitalize on specialized and lucrative niches within the in-vitro diagnostics (IVD) sector.

Additionally, in March 2023, QIAGEN entered into a collaboration with Servier to develop a companion diagnostic test for TIBSOVO, designed for treating acute myeloid leukaemia. This partnership exemplifies the industry's heightened focus on precision medicine, which is driving demand for innovative reagents and consumables. As the field of precision medicine continues to evolve, the need for novel products is expected to grow, positioning the reagents segment as a critical catalyst for market expansion. Companies that invest in this area will be well-positioned to lead in the competitive landscape of IVD solutions.

Key Questions Answered

  • How is the in vitro diagnostics market evolving?
  • What is driving and restraining the in vitro diagnostics market?
  • How will each in vitro diagnostics submarket segment grow over the forecast period and how much revenue will these submarkets account for in 2034?
  • How will the market shares for each in vitro diagnostics submarket develop from 2024 to 2034?
  • What will be the main driver for the overall market from 2024 to 2034?
  • Will leading in vitro diagnostics markets broadly follow the macroeconomic dynamics, or will individual national markets outperform others?
  • How will the market shares of the national markets change by 2034 and which geographical region will lead the market in 2034?
  • Who are the leading players and what are their prospects over the forecast period?
  • What are the in vitro diagnostics projects for these leading companies?
  • How will the industry evolve during the period between 2024 and 2034? What are the implications of
in vitro diagnostics projects taking place now and over the next 10 years?
  • Is there a greater need for product commercialisation to further scale the in vitro diagnostics market?
  • Where is the in vitro diagnostics market heading and how can you ensure you are at the forefront of the market?
  • What are the best investment options for new product and service lines?
  • What are the key prospects for moving companies into a new growth path and C-suite?

You need to discover how this will impact the in vitro diagnostics market today, and over the next 10 years:

  • This 367-page report provides 134 tables and 185 charts/graphs exclusively to you.
  • The report highlights key lucrative areas in the industry so you can target them ‚Äì NOW.
  • It contains in-depth analysis of global, regional and national sales and growth.
  • It highlights for you the key successful trends, changes and revenue projections made by your competitors.

Forecasts to 2034 and other analyses reveal commercial prospects

  • In addition to revenue forecasting to 2034, the new study provides you with recent results, growth rates, and market shares.
  • You will find original analyses, with business outlooks and developments.
  • Discover qualitative analyses (including market dynamics, drivers, opportunities, and restraints), Porter's Five Forces Analysis, PEST Analysis and recent developments.

Segments Covered in the Report

Product

  • Instruments
  • Reagents & Kits

Test

  • Clinical Chemistry
  • Immunoassay/Immunochemistry
  • Molecular Diagnostics
  • Hematology
  • Urinalysis
  • Others

Application

  • Cardiology
  • Diabetes
  • Oncology
  • Infectious Diseases
  • Nephrology
  • Autoimmune Diseases
  • Drug Testing/Pharmacogenomics
  • Others

End-users

  • Academic & Research Institutes
  • Diagnostic Laboratories
  • Hospitals
  • Others
In addition to the revenue predictions for the overall world market and segments, you will also find revenue forecasts for five regional and 20 leading national markets:

North America

  • U.S.
  • Canada

Europe

  • Germany
  • UK
  • France
  • Italy
  • Spain
  • Rest of Europe

Asia Pacific

  • Japan
  • China
  • India
  • Australia
  • South Korea
  • Rest of Asia Pacific

Latin America

  • Brazil
  • Mexico
  • Rest of Latin America

MEA

  • GCC
  • South Africa
  • Rest of MEA
The report also includes profiles for some of the leading companies in the In Vitro Diagnostics Market, with a focus on this segment of these companies' operations.

Leading companies and the potential for market growth

  • QIAGEN
  • BD
  • BioM√©rieux SA
  • F. Hoffmann-La Roche, Ltd.
  • Quidel
  • Ortho Corporation
  • Abbott
  • Agilent Technologies, Inc.
  • Thermofisher Scientific, Inc.
  • Siemens Healthineers AG
  • Bio-Rad Laboratories, Inc.
  • Danaher
  • Sysmex Corporation
  • Charles River Laboratories
  • Quest Diagnostics Incorporated
  • Illumina, Inc.
  • Hologic
  • Revvity
  • Exact Sciences

How will the In Vitro Diagnostics Market report help you?

In summary, the 360+ page report provides you with the following knowledge:
  • Revenue forecasts to 2034 for In Vitro Diagnostics Market 2024 to 2034, with forecasts for Product, Test, Application, and End-users, each forecast at a global and regional level ‚Äì discover the industry's prospects, finding the most lucrative places for investments and revenues.
  • Revenue forecasts to 2034 for five regional and 20 key national markets ‚Äì See forecasts for the In Vitro Diagnostics Market market in North America, Europe, Asia-Pacific, Latin America, and MEA. Also forecasted is the market in the US, Canada, Mexico, Brazil, Germany, France, UK, Italy, China, India, Japan, and Australia among other prominent economies.
  • Prospects for established firms and those seeking to enter the market ‚Äì including company profiles for 19 of the major companies involved in the In Vitro Diagnostics Market.
Find quantitative and qualitative analyses with independent predictions. Receive information that only this report contains, staying informed with invaluable business intelligence.

Information found nowhere else

With this new report, you are less likely to fall behind in knowledge or miss out on opportunities. See how this work could benefit your research, analyses, and decisions. Visiongain's study is for everybody needing commercial analyses for the In Vitro Diagnostics Market 2024 to 2034, market-leading companies. You will find data, trends and predictions.

Table of Contents

1 Report Overview
1.1 Objectives of the Study
1.2 Introduction to In Vitro Diagnostics Market
1.3 What This Report Delivers
1.4 Why You Should Read This Report
1.5 Key Questions Answered by This Analytical Report Include:
1.6 Who is This Report For?
1.7 Methodology
1.7.1 Market Definitions
1.7.2 Market Evaluation & Forecasting Methodology
1.7.3 Data Validation
1.7.3.1 Primary Research
1.7.3.2 Secondary Research
1.8 Frequently Asked Questions (FAQs)
1.9 Associated Reports
1.10 About the Publisher
2 Executive Summary
3 Market Overview
3.1 Key Findings
3.2 Impact Analysis
3.3 Market Driving Factors
3.3.1 Increasing Prevalence of Chronic Diseases
3.3.2 Rising Demand for Personalized Medicine
3.3.3 Advancements in Diagnostic Technologies
3.3.4 Growing Adoption of Point-of-Care Testing
3.3.5 Expanding Healthcare Infrastructure in Emerging Economies
3.3.6 Rising Awareness About Early Disease Detection
3.3.7 Government Initiatives Supporting Healthcare Reforms
3.4 Market Restraining Factors
3.4.1 High Costs of Advanced Diagnostic Tests
3.4.2 Stringent Regulatory Frameworks
3.4.3 Limited Accessibility in Low-resource Regions
3.4.4 Shortage of Skilled Professionals for Handling IVD Devices
3.4.5 Reimbursement Challenges for Novel Diagnostic Tests
3.5 Market Opportunities
3.5.1 Integration of AI and Machine Learning in Diagnostics
3.5.2 Expansion into Untapped Markets in Developing Regions
3.5.3 Growing Demand for Home-based Diagnostics
3.5.4 Development of Advanced Biomarkers
3.5.5 Increasing Collaborations Between Diagnostic Companies and Healthcare Providers
3.5.6 Rising Focus on Preventive Healthcare Strategies
3.5.7 Growth in Molecular Diagnostics and Genetic Testing
3.6 Molecular Diagnostics
3.6.1 Market Forecast by Region, 2024-2034 (US$ Billion, AGR %)
3.6.2 Market Share by Region, 2024 & 2034 (%)
3.7 Hematology
3.7.1 Market Forecast by Region, 2024-2034 (US$ Billion, AGR %)
3.7.2 Market Share by Region, 2024 & 2034 (%)
3.8 Urinalysis
3.8.1 Market Forecast by Region, 2024-2034 (US$ Billion, AGR %)
3.8.2 Market Share by Region, 2024 & 2034 (%)
3.9 Others
3.9.1 Market Forecast by Region, 2024-2034 (US$ Billion, AGR %)
3.9.2 Market Share by Region, 2024 & 2034 (%)
4 In Vitro Diagnostics Market Analysis by Application
4.1 Key Findings
4.2 Application Segment: Market Attractiveness Index
4.3 In Vitro Diagnostics Market Size Estimation and Forecast by Application
4.4 Cardiology
4.4.1 Market Forecast by Region, 2024-2034 (US$ Billion, AGR %)
4.4.2 Market Share by Region, 2024 & 2034 (%)
4.5 Diabetes
4.5.1 Market Forecast by Region, 2024-2034 (US$ Billion, AGR %)
4.5.2 Market Share by Region, 2024 & 2034 (%)
4.6 Oncology
4.6.1 Market Forecast by Region, 2024-2034 (US$ Billion, AGR %)
4.6.2 Market Share by Region, 2024 & 2034 (%)
4.7 Infectious Diseases
4.7.1 Market Forecast by Region, 2024-2034 (US$ Billion, AGR %)
4.7.2 Market Share by Region, 2024 & 2034 (%)
4.8 Nephrology
4.8.1 Market Forecast by Region, 2024-2034 (US$ Billion, AGR %)
4.8.2 Market Share by Region, 2024 & 2034 (%)
4.9 Autoimmune Diseases
4.9.1 Market Forecast by Region, 2024-2034 (US$ Billion, AGR %)
4.9.2 Market Share by Region, 2024 & 2034 (%)
4.10 Drug Testing/Pharmacogenomics
4.10.1 Market Forecast by Region, 2024-2034 (US$ Billion, AGR %)
4.10.2 Market Share by Region, 2024 & 2034 (%)
4.11 Others
4.11.1 Market Forecast by Region, 2024-2034 (US$ Billion, AGR %)
4.11.2 Market Share by Region, 2024 & 2034 (%)
5 In Vitro Diagnostics Market Analysis by End-users
5.1 Key Findings
5.2 End-users Segment: Market Attractiveness Index
5.3 In Vitro Diagnostics Market Size Estimation and Forecast by End-users
5.4 Academic & Research Institutes
5.4.1 Market Forecast by Region, 2024-2034 (US$ Billion, AGR %)
5.4.2 Market Share by Region, 2024 & 2034 (%)
5.5 Diagnostic Laboratories
5.5.1 Market Forecast by Region, 2024-2034 (US$ Billion, AGR %)
5.5.2 Market Share by Region, 2024 & 2034 (%)
5.6 Hospitals
5.6.1 Market Forecast by Region, 2024-2034 (US$ Billion, AGR %)
5.6.2 Market Share by Region, 2024 & 2034 (%)
5.7 Others
5.7.1 Market Forecast by Region, 2024-2034 (US$ Billion, AGR %)
5.7.2 Market Share by Region, 2024 & 2034 (%)
6 In Vitro Diagnostics Market Analysis by Region
6.1 Key Findings
6.2 Regional Market Size Estimation and Forecast
7 North America In Vitro Diagnostics Market Analysis
7.1 Key Findings
7.2 North America In Vitro Diagnostics Market Attractiveness Index
7.3 North America In Vitro Diagnostics Market by Country, 2024, 2029 & 2034 (US$ Billion)
7.4 North America In Vitro Diagnostics Market Size Estimation and Forecast by Country
7.5 North America In Vitro Diagnostics Market Size Estimation and Forecast by Product
7.6 North America In Vitro Diagnostics Market Size Estimation and Forecast by Test
7.7 North America In Vitro Diagnostics Market Size Estimation and Forecast by Application
7.8 North America In Vitro Diagnostics Market Size Estimation and Forecast by End-users
7.9 U.S. In Vitro Diagnostics Market Analysis
7.10 Canada In Vitro Diagnostics Market Analysis
8 Europe In Vitro Diagnostics Market Analysis
8.1 Key Findings
8.2 Europe In Vitro Diagnostics Market Attractiveness Index
8.3 Europe In Vitro Diagnostics Market by Country, 2024, 2029 & 2034 (US$ Billion)
8.4 Europe In Vitro Diagnostics Market Size Estimation and Forecast by Country
8.5 Europe In Vitro Diagnostics Market Size Estimation and Forecast by Product
8.6 Europe In Vitro Diagnostics Market Size Estimation and Forecast by Test
8.7 Europe In Vitro Diagnostics Market Size Estimation and Forecast by Application
8.8 Europe In Vitro Diagnostics Market Size Estimation and Forecast by End-users
8.9 Germany In Vitro Diagnostics Market Analysis
8.10 UK In Vitro Diagnostics Market Analysis
8.11 France In Vitro Diagnostics Market Analysis
8.12 Italy In Vitro Diagnostics Market Analysis
8.13 Spain In Vitro Diagnostics Market Analysis
8.14 Russia In Vitro Diagnostics Market Analysis
8.15 Rest of Europe In Vitro Diagnostics Market Analysis
9 Asia Pacific In Vitro Diagnostics Market Analysis
9.1 Key Findings
9.2 Asia Pacific In Vitro Diagnostics Market Attractiveness Index
9.3 Asia Pacific In Vitro Diagnostics Market by Country, 2024, 2029 & 2034 (US$ Billion)
9.4 Asia Pacific In Vitro Diagnostics Market Size Estimation and Forecast by Country
9.5 Asia Pacific In Vitro Diagnostics Market Size Estimation and Forecast by Product
9.6 Asia Pacific In Vitro Diagnostics Market Size Estimation and Forecast by Test
9.7 Asia Pacific In Vitro Diagnostics Market Size Estimation and Forecast by Application
9.8 Asia Pacific In Vitro Diagnostics Market Size Estimation and Forecast by End-users
9.9 Japan In Vitro Diagnostics Market Analysis
9.10 China In Vitro Diagnostics Market Analysis
9.11 India In Vitro Diagnostics Market Analysis
9.12 Australia In Vitro Diagnostics Market Analysis
9.13 South Korea In Vitro Diagnostics Market Analysis
9.14 Rest of Asia Pacific In Vitro Diagnostics Market Analysis
10 Latin America In Vitro Diagnostics Market Analysis
10.1 Key Findings
10.2 Latin America In Vitro Diagnostics Market Attractiveness Index
10.3 Latin America In Vitro Diagnostics Market by Country, 2024, 2029 & 2034 (US$ Billion)
10.4 Latin America In Vitro Diagnostics Market Size Estimation and Forecast by Country
10.5 Latin America In Vitro Diagnostics Market Size Estimation and Forecast by Product
10.6 Latin America In Vitro Diagnostics Market Size Estimation and Forecast by Test
10.7 Latin America In Vitro Diagnostics Market Size Estimation and Forecast by Application
10.8 Latin America In Vitro Diagnostics Market Size Estimation and Forecast by End-users
10.9 Brazil In Vitro Diagnostics Market Analysis
10.10 Mexico In Vitro Diagnostics Market Analysis
10.11 Argentina In Vitro Diagnostics Market Analysis
10.12 Colombia In Vitro Diagnostics Market Analysis
10.13 Rest of Latin America In Vitro Diagnostics Market Analysis
11 MEA In Vitro Diagnostics Market Analysis
11.1 Key Findings
11.2 MEA In Vitro Diagnostics Market Attractiveness Index
11.3 MEA In Vitro Diagnostics Market by Country, 2024, 2029 & 2034 (US$ Billion)
11.4 MEA In Vitro Diagnostics Market Size Estimation and Forecast by Country
11.5 MEA In Vitro Diagnostics Market Size Estimation and Forecast by Product
11.6 MEA In Vitro Diagnostics Market Size Estimation and Forecast by Test
11.7 MEA In Vitro Diagnostics Market Size Estimation and Forecast by Application
11.8 MEA In Vitro Diagnostics Market Size Estimation and Forecast by End-users
11.9 GCC In Vitro Diagnostics Market Analysis
11.10 South Africa In Vitro Diagnostics Market Analysis
11.11 Rest of MEA In Vitro Diagnostics Market Analysis
12 Company Profiles
12.1 QIAGEN
12.1.1 Company Snapshot
12.1.2 Company Overview
12.1.3 Company Financials
12.1.3.1 Revenue, 2021-2023 (US$ Million)
12.1.3.2 R&D, 2021-2023 (US$ Million)
12.1.3.3 Regional Shares, 2023 (%)
12.1.3.4 Business Segment Market Shares, 2023 (%)
12.1.4 Product Benchmarking
12.1.5 Strategic Outlook
12.2 BD
12.2.1 Company Snapshot
12.2.2 Company Overview
12.2.3 Company Financials
12.2.3.1 Revenue, 2021-2023 (US$ Million)
12.2.3.2 R&D, 2021-2023 (US$ Million)
12.2.3.3 Regional Shares, 2023 (%)
12.2.3.4 Business Segment Market Shares, 2023 (%)
12.2.4 Product Benchmarking
12.2.5 Strategic Outlook
12.3 BioMv©rieux SA
12.3.1 Company Snapshot
12.3.2 Company Overview
12.3.3 Company Financials
12.3.3.1 Revenue, 2021-2023 (US$ Million)
12.3.3.2 R&D, 2021-2023 (US$ Million)
12.3.3.3 Regional Shares, 2023 (%)
12.3.3.4 Business Segment Market Shares, 2023 (%)
12.3.4 Product Benchmarking
12.3.5 Strategic Outlook
12.4 F. Hoffmann-La Roche, Ltd.
12.4.1 Company Snapshot
12.4.2 Company Overview
12.4.3 Company Financials
12.4.3.1 Revenue, 2021-2023 (US$ Million)
12.4.3.2 R&D, 2021-2023 (US$ Million)
12.4.3.3 Regional Shares, 2023 (%)
12.4.3.4 Business Segment Market Shares, 2023 (%)
12.4.4 Product Benchmarking
12.4.5 Strategic Outlook
12.5 Quidel
12.5.1 Company Snapshot
12.5.2 Company Overview
12.5.3 Company Financials
12.5.3.1 Revenue, 2021-2023 (US$ Million)
12.5.3.2 R&D, 2021-2023 (US$ Million)
12.5.3.3 Regional Shares, 2023 (%)
12.5.3.4 Business Segment Market Shares, 2023 (%)
12.5.4 Product Benchmarking
12.5.5 Strategic Outlook
12.6 Ortho Corporation
12.6.1 Company Snapshot
12.6.2 Company Overview
12.6.3 Company Financials
12.6.3.1 Revenue, 2021-2023 (US$ Million)
12.6.3.2 R&D, 2021-2023 (US$ Million)
12.6.3.3 Regional Shares, 2023 (%)
12.6.3.4 Business Segment Market Shares, 2023 (%)
12.6.4 Product Benchmarking
12.6.5 Strategic Outlook
12.7 Abbott
12.7.1 Company Snapshot
12.7.2 Company Overview
12.7.3 Company Financials
12.7.3.1 Revenue, 2021-2023 (US$ Million)
12.7.3.2 R&D, 2021-2023 (US$ Million)
12.7.3.3 Regional Shares, 2023 (%)
12.7.3.4 Business Segment Market Shares, 2023 (%)
12.7.4 Product Benchmarking
12.7.5 Strategic Outlook
12.8 Agilent Technologies, Inc.
12.8.1 Company Snapshot
12.8.2 Company Overview
12.8.3 Company Financials
12.8.3.1 Revenue, 2021-2023 (US$ Million)
12.8.3.2 R&D, 2021-2023 (US$ Million)
12.8.3.3 Regional Shares, 2023 (%)
12.8.3.4 Business Segment Market Shares, 2023 (%)
12.8.4 Product Benchmarking
12.8.5 Strategic Outlook
12.9 Thermofisher Scientific, Inc.
12.9.1 Company Snapshot
12.9.2 Company Overview
12.9.3 Company Financials
12.9.3.1 Revenue, 2021-2023 (US$ Million)
12.9.3.2 R&D, 2021-2023 (US$ Million)
12.9.3.3 Regional Shares, 2023 (%)
12.9.3.4 Business Segment Market Shares, 2023 (%)
12.9.4 Product Benchmarking
12.9.5 Strategic Outlook
12.10 Siemens Healthineers AG
12.10.1 Company Snapshot
12.10.2 Company Overview
12.10.3 Company Financials
12.10.3.1 Revenue, 2021-2023 (US$ Million)
12.10.3.2 R&D, 2021-2023 (US$ Million)
12.10.3.3 Regional Shares, 2023 (%)
12.10.3.4 Business Segment Market Shares, 2023 (%)
12.10.4 Product Benchmarking
12.10.5 Strategic Outlook
12.11 Bio-Rad Laboratories, Inc.
12.11.1 Company Snapshot
12.11.2 Company Overview
12.11.3 Company Financials
12.11.3.1 Revenue, 2021-2023 (US$ Million)
12.11.3.2 R&D, 2021-2023 (US$ Million)
12.11.3.3 Regional Shares, 2023 (%)
12.11.3.4 Business Segment Market Shares, 2023 (%)
12.11.4 Product Benchmarking
12.11.5 Strategic Outlook
12.12 Danaher
12.12.1 Company Snapshot
12.12.2 Company Overview
12.12.3 Company Financials
12.12.3.1 Revenue, 2021-2023 (US$ Million)
12.12.3.2 R&D, 2021-2023 (US$ Million)
12.12.3.3 Regional Shares, 2023 (%)
12.12.3.4 Business Segment Market Shares, 2023 (%)
12.12.4 Product Benchmarking
12.12.5 Strategic Outlook
12.13 Sysmex Corporation
12.13.1 Company Snapshot
12.13.2 Company Overview
12.13.3 Company Financials
12.13.3.1 Revenue, 2021-2023 (US$ Million)
12.13.3.2 R&D, 2021-2023 (US$ Million)
12.13.3.3 Regional Shares, 2023 (%)
12.13.3.4 Business Segment Market Shares, 2023 (%)
12.13.4 Product Benchmarking
12.13.5 Strategic Outlook
12.14 Charles River Laboratories
12.14.1 Company Snapshot
12.14.2 Company Overview
12.14.3 Company Financials
12.14.3.1 Revenue, 2021-2023 (US$ Million)
12.14.3.2 R&D, 2021-2023 (US$ Million)
12.14.3.3 Regional Shares, 2023 (%)
12.14.3.4 Business Segment Market Shares, 2023 (%)
12.14.4 Product Benchmarking
12.14.5 Strategic Outlook
12.15 Quest Diagnostics Incorporated
12.15.1 Company Snapshot
12.15.2 Company Overview
12.15.3 Company Financials
12.15.3.1 Revenue, 2021-2023 (US$ Million)
12.15.3.2 R&D, 2021-2023 (US$ Million)
12.15.3.3 Regional Shares, 2023 (%)
12.15.3.4 Business Segment Market Shares, 2023 (%)
12.15.4 Product Benchmarking
12.15.5 Strategic Outlook
12.16 Illumina, Inc.
12.16.1 Company Snapshot
12.16.2 Company Overview
12.16.3 Company Financials
12.16.3.1 Revenue, 2021-2023 (US$ Million)
12.16.3.2 R&D, 2021-2023 (US$ Million)
12.16.3.3 Regional Shares, 2023 (%)
12.16.3.4 Business Segment Market Shares, 2023 (%)
12.16.4 Product Benchmarking
12.16.5 Strategic Outlook
12.17 Hologic
12.17.1 Company Snapshot
12.17.2 Company Overview
12.17.3 Company Financials
12.17.3.1 Revenue, 2021-2023 (US$ Million)
12.17.3.2 R&D, 2021-2023 (US$ Million)
12.17.3.3 Regional Shares, 2023 (%)
12.17.3.4 Business Segment Market Shares, 2023 (%)
12.17.4 Product Benchmarking
12.17.5 Strategic Outlook
12.18 Revvity
12.18.1 Company Snapshot
12.18.2 Company Overview
12.18.3 Company Financials
12.18.3.1 Revenue, 2021-2023 (US$ Million)
12.18.3.2 R&D, 2021-2023 (US$ Million)
12.18.3.3 Regional Shares, 2023 (%)
12.18.3.4 Business Segment Market Shares, 2023 (%)
12.18.4 Product Benchmarking
12.18.5 Strategic Outlook
12.19 Exact Sciences
12.19.1 Company Snapshot
12.19.2 Company Overview
12.19.3 Company Financials
12.19.3.1 Revenue, 2021-2023 (US$ Million)
12.19.3.2 R&D, 2021-2023 (US$ Million)
12.19.3.3 Regional Shares, 2023 (%)
12.19.3.4 Business Segment Market Shares, 2023 (%)
12.19.4 Product Benchmarking
12.19.5 Strategic Outlook
12.20 Company20
12.20.1 Company Snapshot
12.20.2 Company Overview
12.20.3 Company Financials
12.20.3.1 Revenue, 2021-2023 (US$ Million)
12.20.3.2 R&D, 2021-2023 (US$ Million)
12.20.3.3 Regional Shares, 2023 (%)
12.20.3.4 Business Segment Market Shares, 2023 (%)
12.20.4 Product Benchmarking
12.20.5 Strategic Outlook
13 Conclusion and Recommendations
13.1 Concluding Remarks
13.2 Recommendations for Market Players
List of Tables
Table 1 In Vitro Diagnostics Market Snapshot, 2024 & 2034 (US$ Billion, CAGR %)
Table 2 In Vitro Diagnostics Market Forecast by Product, 2024-2034 (US$ Billion, AGR %, CAGR %)
Table 3 Instruments Segment Market Forecast by Region, 2024-2034 (US$ Billion, AGR %, CAGR %)
Table 4 Reagents & Kits Segment Market Forecast by Region, 2024-2034 (US$ Billion, AGR %, CAGR %)
Table 5 In Vitro Diagnostics Market Forecast by Test, 2024-2034 (US$ Billion, AGR %, CAGR %)
Table 6 Clinical Chemistry Segment Market Forecast by Region, 2024-2034 (US$ Billion, AGR %, CAGR %)
Table 7 Immunoassay/Immunochemistry Segment Market Forecast by Region, 2024-2034 (US$ Billion, AGR %, CAGR %)
Table 8 Molecular Diagnostics Segment Market Forecast by Region, 2024-2034 (US$ Billion, AGR %, CAGR %)
Table 9 Hematology Segment Market Forecast by Region, 2024-2034 (US$ Billion, AGR %, CAGR %)
Table 10 Urinalysis Segment Market Forecast by Region, 2024-2034 (US$ Billion, AGR %, CAGR %)
Table 11 Others Segment Market Forecast by Region, 2024-2034 (US$ Billion, AGR %, CAGR %)
Table 12 In Vitro Diagnostics Market Forecast by Application, 2024-2034 (US$ Billion, AGR %, CAGR %)
Table 13 Cardiology Segment Market Forecast by Region, 2024-2034 (US$ Billion, AGR %, CAGR %)
Table 14 Diabetes Segment Market Forecast by Region, 2024-2034 (US$ Billion, AGR %, CAGR %)
Table 15 Oncology Segment Market Forecast by Region, 2024-2034 (US$ Billion, AGR %, CAGR %)
Table 16 Infectious Diseases Segment Market Forecast by Region, 2024-2034 (US$ Billion, AGR %, CAGR %)
Table 17 Nephrology Segment Market Forecast by Region, 2024-2034 (US$ Billion, AGR %, CAGR %)
Table 18 Autoimmune Diseases Segment Market Forecast by Region, 2024-2034 (US$ Billion, AGR %, CAGR %)
Table 19 Drug Testing/Pharmacogenomics Segment Market Forecast by Region, 2024-2034 (US$ Billion, AGR %, CAGR %)
Table 20 Others Segment Market Forecast by Region, 2024-2034 (US$ Billion, AGR %, CAGR %)
Table 21 In Vitro Diagnostics Market Forecast by End-users, 2024-2034 (US$ Billion, AGR %, CAGR %)
Table 22 Academic & Research Institutes Segment Market Forecast by Region, 2024-2034 (US$ Billion, AGR %, CAGR %)
Table 23 Diagnostic Laboratories Segment Market Forecast by Region, 2024-2034 (US$ Billion, AGR %, CAGR %)
Table 24 Hospitals Segment Market Forecast by Region, 2024-2034 (US$ Billion, AGR %, CAGR %)
Table 25 Others Segment Market Forecast by Region, 2024-2034 (US$ Billion, AGR %, CAGR %)
Table 26 In Vitro Diagnostics Market Forecast by Region, 2024-2034 (US$ Billion, AGR %, CAGR %)
Table 27 North America In Vitro Diagnostics Market Forecast by Country, 2024-2034 (US$ Billion, AGR %, CAGR %)
Table 28 North America In Vitro Diagnostics Market Forecast by Product, 2024-2034 (US$ Billion, AGR %, CAGR %)
Table 29 North America In Vitro Diagnostics Market Forecast by Test, 2024-2034 (US$ Billion, AGR %, CAGR %)
Table 30 North America In Vitro Diagnostics Market Forecast by Application, 2024-2034 (US$ Billion, AGR %, CAGR %)
Table 31 North America In Vitro Diagnostics Market Forecast by End-users, 2024-2034 (US$ Billion, AGR %, CAGR %)
Table 32 U.S. In Vitro Diagnostics Market Forecast, 2024-2034 (US$ Billion, AGR %, CAGR %)
Table 33 Canada In Vitro Diagnostics Market Forecast, 2024-2034 (US$ Billion, AGR %, CAGR %)
Table 34 Europe In Vitro Diagnostics Market Forecast by Country, 2024-2034 (US$ Billion, AGR %, CAGR %)
Table 35 Europe In Vitro Diagnostics Market Forecast by Product, 2024-2034 (US$ Billion, AGR %, CAGR %)
Table 36 Europe In Vitro Diagnostics Market Forecast by Test, 2024-2034 (US$ Billion, AGR %, CAGR %)
Table 37 Europe In Vitro Diagnostics Market Forecast by Application, 2024-2034 (US$ Billion, AGR %, CAGR %)
Table 38 Europe In Vitro Diagnostics Market Forecast by End-users, 2024-2034 (US$ Billion, AGR %, CAGR %)
Table 39 Germany In Vitro Diagnostics Market Forecast, 2024-2034 (US$ Billion, AGR %, CAGR %)
Table 40 UK In Vitro Diagnostics Market Forecast, 2024-2034 (US$ Billion, AGR %, CAGR %)
Table 41 France In Vitro Diagnostics Market Forecast, 2024-2034 (US$ Billion, AGR %, CAGR %)
Table 42 Italy In Vitro Diagnostics Market Forecast, 2024-2034 (US$ Billion, AGR %, CAGR %)
Table 43 Spain In Vitro Diagnostics Market Forecast, 2024-2034 (US$ Billion, AGR %, CAGR %)
Table 44 Russia In Vitro Diagnostics Market Forecast, 2024-2034 (US$ Billion, AGR %, CAGR %)
Table 45 Rest of Europe In Vitro Diagnostics Market Forecast, 2024-2034 (US$ Billion, AGR %, CAGR %)
Table 46 Asia Pacific In Vitro Diagnostics Market Forecast by Country, 2024-2034 (US$ Billion, AGR %, CAGR %)
Table 47 Asia Pacific In Vitro Diagnostics Market Forecast by Product, 2024-2034 (US$ Billion, AGR %, CAGR %)
Table 48 Asia Pacific In Vitro Diagnostics Market Forecast by Test, 2024-2034 (US$ Billion, AGR %, CAGR %)
Table 49 Asia Pacific In Vitro Diagnostics Market Forecast by Application, 2024-2034 (US$ Billion, AGR %, CAGR %)
Table 50 Asia Pacific In Vitro Diagnostics Market Forecast by End-users, 2024-2034 (US$ Billion, AGR %, CAGR %)
Table 51 Japan In Vitro Diagnostics Market Forecast, 2024-2034 (US$ Billion, AGR %, CAGR %)
Table 52 China In Vitro Diagnostics Market Forecast, 2024-2034 (US$ Billion, AGR %, CAGR %)
Table 53 India In Vitro Diagnostics Market Forecast, 2024-2034 (US$ Billion, AGR %, CAGR %)
Table 54 Australia In Vitro Diagnostics Market Forecast, 2024-2034 (US$ Billion, AGR %, CAGR %)
Table 55 South Korea In Vitro Diagnostics Market Forecast, 2024-2034 (US$ Billion, AGR %, CAGR %)
Table 56 Rest of Asia Pacific In Vitro Diagnostics Market Forecast, 2024-2034 (US$ Billion, AGR %, CAGR %)
Table 57 Latin America In Vitro Diagnostics Market Forecast by Country, 2024-2034 (US$ Billion, AGR %, CAGR %)
Table 58 Latin America In Vitro Diagnostics Market Forecast by Product, 2024-2034 (US$ Billion, AGR %, CAGR %)
Table 59 Latin America In Vitro Diagnostics Market Forecast by Test, 2024-2034 (US$ Billion, AGR %, CAGR %)
Table 60 Latin America In Vitro Diagnostics Market Forecast by Application, 2024-2034 (US$ Billion, AGR %, CAGR %)
Table 61 Latin America In Vitro Diagnostics Market Forecast by End-users, 2024-2034 (US$ Billion, AGR %, CAGR %)
Table 62 Brazil In Vitro Diagnostics Market Forecast, 2024-2034 (US$ Billion, AGR %, CAGR %)
Table 63 Mexico In Vitro Diagnostics Market Forecast, 2024-2034 (US$ Billion, AGR %, CAGR %)
Table 64 Argentina In Vitro Diagnostics Market Forecast, 2024-2034 (US$ Billion, AGR %, CAGR %)
Table 65 Colombia In Vitro Diagnostics Market Forecast, 2024-2034 (US$ Billion, AGR %, CAGR %)
Table 66 Rest of Latin America In Vitro Diagnostics Market Forecast, 2024-2034 (US$ Billion, AGR %, CAGR %)
Table 67 MEA In Vitro Diagnostics Market Forecast by Country, 2024-2034 (US$ Billion, AGR %, CAGR %)
Table 68 MEA In Vitro Diagnostics Market Forecast by Product, 2024-2034 (US$ Billion, AGR %, CAGR %)
Table 69 MEA In Vitro Diagnostics Market Forecast by Test, 2024-2034 (US$ Billion, AGR %, CAGR %)
Table 70 MEA In Vitro Diagnostics Market Forecast by Application, 2024-2034 (US$ Billion, AGR %, CAGR %)
Table 71 MEA In Vitro Diagnostics Market Forecast by End-users, 2024-2034 (US$ Billion, AGR %, CAGR %)
Table 72 GCC In Vitro Diagnostics Market Forecast, 2024-2034 (US$ Billion, AGR %, CAGR %)
Table 73 South Africa In Vitro Diagnostics Market Forecast, 2024-2034 (US$ Billion, AGR %, CAGR %)
Table 74 Rest of MEA In Vitro Diagnostics Market Forecast, 2024-2034 (US$ Billion, AGR %, CAGR %)
Table 75 QIAGEN: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 76 QIAGEN: Product Benchmarking
Table 77 QIAGEN: Strategic Outlook
Table 78 BD: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 79 BD: Product Benchmarking
Table 80 BD: Strategic Outlook
Table 81 BioMv©rieux SA: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 82 BioMv©rieux SA: Product Benchmarking
Table 83 BioMv©rieux SA: Strategic Outlook
Table 84 F. Hoffmann-La Roche, Ltd.: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 85 F. Hoffmann-La Roche, Ltd.: Product Benchmarking
Table 86 F. Hoffmann-La Roche, Ltd.: Strategic Outlook
Table 87 Quidel: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 88 Quidel: Product Benchmarking
Table 89 Quidel: Strategic Outlook
Table 90 Ortho Corporation: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 91 Ortho Corporation: Product Benchmarking
Table 92 Ortho Corporation: Strategic Outlook
Table 93 Abbott: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 94 Abbott: Product Benchmarking
Table 95 Abbott: Strategic Outlook
Table 96 Agilent Technologies, Inc.: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 97 Agilent Technologies, Inc.: Product Benchmarking
Table 98 Agilent Technologies, Inc.: Strategic Outlook
Table 99 Thermofisher Scientific, Inc.: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 100 Thermofisher Scientific, Inc.: Product Benchmarking
Table 101 Thermofisher Scientific, Inc.: Strategic Outlook
Table 102 Siemens Healthineers AG: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 103 Siemens Healthineers AG: Product Benchmarking
Table 104 Siemens Healthineers AG: Strategic Outlook
Table 105 Bio-Rad Laboratories, Inc.: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 106 Bio-Rad Laboratories, Inc.: Product Benchmarking
Table 107 Bio-Rad Laboratories, Inc.: Strategic Outlook
Table 108 Danaher: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 109 Danaher: Product Benchmarking
Table 110 Danaher: Strategic Outlook
Table 111 Sysmex Corporation: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 112 Sysmex Corporation: Product Benchmarking
Table 113 Sysmex Corporation: Strategic Outlook
Table 114 Charles River Laboratories: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 115 Charles River Laboratories: Product Benchmarking
Table 116 Charles River Laboratories: Strategic Outlook
Table 117 Quest Diagnostics Incorporated: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 118 Quest Diagnostics Incorporated: Product Benchmarking
Table 119 Quest Diagnostics Incorporated: Strategic Outlook
Table 120 Illumina, Inc.: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 121 Illumina, Inc.: Product Benchmarking
Table 122 Illumina, Inc.: Strategic Outlook
Table 123 Hologic: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 124 Hologic: Product Benchmarking
Table 125 Hologic: Strategic Outlook
Table 126 Revvity: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 127 Revvity: Product Benchmarking
Table 128 Revvity: Strategic Outlook
Table 129 Exact Sciences: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 130 Exact Sciences: Product Benchmarking
Table 131 Exact Sciences: Strategic Outlook
Table 132 Company20: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 133 Company20: Product Benchmarking
Table 134 Company20: Strategic Outlook
List of Figures
Figure 1 In Vitro Diagnostics Market Segmentation
Figure 2 In Vitro Diagnostics Market by Product: Market Attractiveness Index
Figure 3 In Vitro Diagnostics Market by Test: Market Attractiveness Index
Figure 4 In Vitro Diagnostics Market by Application: Market Attractiveness Index
Figure 5 In Vitro Diagnostics Market by End-users: Market Attractiveness Index
Figure 6 In Vitro Diagnostics Market Attractiveness Index by Region
Figure 7 In Vitro Diagnostics Market: Market Dynamics
Figure 8 In Vitro Diagnostics Market: Porter's Five Forces Analysis
Figure 9 In Vitro Diagnostics Market: PEST Analysis
Figure 10 In Vitro Diagnostics Market Attractiveness Index by Product
Figure 11 In Vitro Diagnostics Market Forecast by Product, 2024-2034 (US$ Billion, AGR %)
Figure 12 In Vitro Diagnostics Market Share Forecast by Product, 2024, 2029, 2034 (%)
Figure 13 Instruments Segment Market Forecast by Region, 2024-2034 (US$ Billion, AGR %)
Figure 14 Instruments Segment Market Share Forecast by Region, 2024 & 2034 (%)
Figure 15 Reagents & Kits Segment Market Forecast by Region, 2024-2034 (US$ Billion, AGR %)
Figure 16 Reagents & Kits Segment Market Share Forecast by Region, 2024 & 2034 (%)
Figure 17 In Vitro Diagnostics Market Attractiveness Index by Test
Figure 18 In Vitro Diagnostics Market Forecast by Test, 2024-2034 (US$ Billion, AGR %)
Figure 19 In Vitro Diagnostics Market Share Forecast by Test, 2024, 2029, 2034 (%)
Figure 20 Clinical Chemistry Segment Market Forecast by Region, 2024-2034 (US$ Billion, AGR %)
Figure 21 Clinical Chemistry Segment Market Share Forecast by Region, 2024 & 2034 (%)
Figure 22 Immunoassay/Immunochemistry Segment Market Forecast by Region, 2024-2034 (US$ Billion, AGR %)
Figure 23 Immunoassay/Immunochemistry Segment Market Share Forecast by Region, 2024 & 2034 (%)
Figure 24 Molecular Diagnostics Segment Market Forecast by Region, 2024-2034 (US$ Billion, AGR %)
Figure 25 Molecular Diagnostics Segment Market Share Forecast by Region, 2024 & 2034 (%)
Figure 26 Hematology Segment Market Forecast by Region, 2024-2034 (US$ Billion, AGR %)
Figure 27 Hematology Segment Market Share Forecast by Region, 2024 & 2034 (%)
Figure 28 Urinalysis Segment Market Forecast by Region, 2024-2034 (US$ Billion, AGR %)
Figure 29 Urinalysis Segment Market Share Forecast by Region, 2024 & 2034 (%)
Figure 30 Others Segment Market Forecast by Region, 2024-2034 (US$ Billion, AGR %)
Figure 31 Others Segment Market Share Forecast by Region, 2024 & 2034 (%)
Figure 32 In Vitro Diagnostics Market Attractiveness Index by Application
Figure 33 In Vitro Diagnostics Market Forecast by Application, 2024-2034 (US$ Billion, AGR %)
Figure 34 In Vitro Diagnostics Market Share Forecast by Application, 2024, 2029, 2034 (%)
Figure 35 Cardiology Segment Market Forecast by Region, 2024-2034 (US$ Billion, AGR %)
Figure 36 Cardiology Segment Market Share Forecast by Region, 2024 & 2034 (%)
Figure 37 Diabetes Segment Market Forecast by Region, 2024-2034 (US$ Billion, AGR %)
Figure 38 Diabetes Segment Market Share Forecast by Region, 2024 & 2034 (%)
Figure 39 Oncology Segment Market Forecast by Region, 2024-2034 (US$ Billion, AGR %)
Figure 40 Oncology Segment Market Share Forecast by Region, 2024 & 2034 (%)
Figure 41 Infectious Diseases Segment Market Forecast by Region, 2024-2034 (US$ Billion, AGR %)
Figure 42 Infectious Diseases Segment Market Share Forecast by Region, 2024 & 2034 (%)
Figure 43 Nephrology Segment Market Forecast by Region, 2024-2034 (US$ Billion, AGR %)
Figure 44 Nephrology Segment Market Share Forecast by Region, 2024 & 2034 (%)
Figure 45 Autoimmune Diseases Segment Market Forecast by Region, 2024-2034 (US$ Billion, AGR %)
Figure 46 Autoimmune Diseases Segment Market Share Forecast by Region, 2024 & 2034 (%)
Figure 47 Drug Testing/Pharmacogenomics Segment Market Forecast by Region, 2024-2034 (US$ Billion, AGR %)
Figure 48 Drug Testing/Pharmacogenomics Segment Market Share Forecast by Region, 2024 & 2034 (%)
Figure 49 Others Segment Market Forecast by Region, 2024-2034 (US$ Billion, AGR %)
Figure 50 Others Segment Market Share Forecast by Region, 2024 & 2034 (%)
Figure 51 In Vitro Diagnostics Market Attractiveness Index by End-users
Figure 52 In Vitro Diagnostics Market Forecast by End-users, 2024-2034 (US$ Billion, AGR %)
Figure 53 In Vitro Diagnostics Market Share Forecast by End-users, 2024, 2029, 2034 (%)
Figure 54 Academic & Research Institutes Segment Market Forecast by Region, 2024-2034 (US$ Billion, AGR %)
Figure 55 Academic & Research Institutes Segment Market Share Forecast by Region, 2024 & 2034 (%)
Figure 56 Diagnostic Laboratories Segment Market Forecast by Region, 2024-2034 (US$ Billion, AGR %)
Figure 57 Diagnostic Laboratories Segment Market Share Forecast by Region, 2024 & 2034 (%)
Figure 58 Hospitals Segment Market Forecast by Region, 2024-2034 (US$ Billion, AGR %)
Figure 59 Hospitals Segment Market Share Forecast by Region, 2024 & 2034 (%)
Figure 60 Others Segment Market Forecast by Region, 2024-2034 (US$ Billion, AGR %)
Figure 61 Others Segment Market Share Forecast by Region, 2024 & 2034 (%)
Figure 62 In Vitro Diagnostics Market Forecast by Region 2024, 2029, 2034 (Revenue, CAGR%)
Figure 63 In Vitro Diagnostics Market Share Forecast by Region 2024, 2029, 2034 (%)
Figure 64 In Vitro Diagnostics Market by Region, 2024-2034 (US$ Bn, AGR %)
Figure 65 North America In Vitro Diagnostics Market Attractiveness Index
Figure 66 North America In Vitro Diagnostics Market by Region, 2024, 2029 & 2034 (US$ Billion)
Figure 67 North America In Vitro Diagnostics Market Forecast by Country, 2024-2034 (US$ Billion, AGR %)
Figure 68 North America In Vitro Diagnostics Market Forecast by Product, 2024-2034 (US$ Billion, AGR %)
Figure 69 North America In Vitro Diagnostics Market Forecast by Test, 2024-2034 (US$ Billion, AGR %)
Figure 70 North America In Vitro Diagnostics Market Forecast by Application, 2024-2034 (US$ Billion, AGR %)
Figure 71 North America In Vitro Diagnostics Market Forecast by End-users, 2024-2034 (US$ Billion, AGR %)
Figure 72 U.S. In Vitro Diagnostics Market Forecast, 2024-2034 (US$ Billion, AGR %)
Figure 73 Canada In Vitro Diagnostics Market Forecast, 2024-2034 (US$ Billion, AGR %)
Figure 74 Europe In Vitro Diagnostics Market Attractiveness Index
Figure 75 Europe In Vitro Diagnostics Market by Region, 2024, 2029 & 2034 (US$ Billion)
Figure 76 Europe In Vitro Diagnostics Market Forecast by Country, 2024-2034 (US$ Billion, AGR %)
Figure 77 Europe In Vitro Diagnostics Market Forecast by Product, 2024-2034 (US$ Billion, AGR %)
Figure 78 Europe In Vitro Diagnostics Market Forecast by Test, 2024-2034 (US$ Billion, AGR %)
Figure 79 Europe In Vitro Diagnostics Market Forecast by Application, 2024-2034 (US$ Billion, AGR %)
Figure 80 Europe In Vitro Diagnostics Market Forecast by End-users, 2024-2034 (US$ Billion, AGR %)
Figure 81 Germany In Vitro Diagnostics Market Forecast, 2024-2034 (US$ Billion, AGR %)
Figure 82 UK In Vitro Diagnostics Market Forecast, 2024-2034 (US$ Billion, AGR %)
Figure 83 France In Vitro Diagnostics Market Forecast, 2024-2034 (US$ Billion, AGR %)
Figure 84 Italy In Vitro Diagnostics Market Forecast, 2024-2034 (US$ Billion, AGR %)
Figure 85 Spain In Vitro Diagnostics Market Forecast, 2024-2034 (US$ Billion, AGR %)
Figure 86 Russia In Vitro Diagnostics Market Forecast, 2024-2034 (US$ Billion, AGR %)
Figure 87 Rest of Europe In Vitro Diagnostics Market Forecast, 2024-2034 (US$ Billion, AGR %)
Figure 88 Asia Pacific In Vitro Diagnostics Market Attractiveness Index
Figure 89 Asia Pacific In Vitro Diagnostics Market by Region, 2024, 2029 & 2034 (US$ Billion)
Figure 90 Asia Pacific In Vitro Diagnostics Market Forecast by Country, 2024-2034 (US$ Billion, AGR %)
Figure 91 Asia Pacific In Vitro Diagnostics Market Forecast by Product, 2024-2034 (US$ Billion, AGR %)
Figure 92 Asia Pacific In Vitro Diagnostics Market Forecast by Test, 2024-2034 (US$ Billion, AGR %)
Figure 93 Asia Pacific In Vitro Diagnostics Market Forecast by Application, 2024-2034 (US$ Billion, AGR %)
Figure 94 Asia Pacific In Vitro Diagnostics Market Forecast by End-users, 2024-2034 (US$ Billion, AGR %)
Figure 95 Japan In Vitro Diagnostics Market Forecast, 2024-2034 (US$ Billion, AGR %)
Figure 96 China In Vitro Diagnostics Market Forecast, 2024-2034 (US$ Billion, AGR %)
Figure 97 India In Vitro Diagnostics Market Forecast, 2024-2034 (US$ Billion, AGR %)
Figure 98 Australia In Vitro Diagnostics Market Forecast, 2024-2034 (US$ Billion, AGR %)
Figure 99 South Korea In Vitro Diagnostics Market Forecast, 2024-2034 (US$ Billion, AGR %)
Figure 100 Rest of Asia Pacific In Vitro Diagnostics Market Forecast, 2024-2034 (US$ Billion, AGR %)
Figure 101 Latin America In Vitro Diagnostics Market Attractiveness Index
Figure 102 Latin America In Vitro Diagnostics Market by Region, 2024, 2029 & 2034 (US$ Billion)
Figure 103 Latin America In Vitro Diagnostics Market Forecast by Country, 2024-2034 (US$ Billion, AGR %)
Figure 104 Latin America In Vitro Diagnostics Market Forecast by Product, 2024-2034 (US$ Billion, AGR %)
Figure 105 Latin America In Vitro Diagnostics Market Forecast by Test, 2024-2034 (US$ Billion, AGR %)
Figure 106 Latin America In Vitro Diagnostics Market Forecast by Application, 2024-2034 (US$ Billion, AGR %)
Figure 107 Latin America In Vitro Diagnostics Market Forecast by End-users, 2024-2034 (US$ Billion, AGR %)
Figure 108 Brazil In Vitro Diagnostics Market Forecast, 2024-2034 (US$ Billion, AGR %)
Figure 109 Mexico In Vitro Diagnostics Market Forecast, 2024-2034 (US$ Billion, AGR %)
Figure 110 Argentina In Vitro Diagnostics Market Forecast, 2024-2034 (US$ Billion, AGR %)
Figure 111 Colombia In Vitro Diagnostics Market Forecast, 2024-2034 (US$ Billion, AGR %)
Figure 112 Rest of Latin America In Vitro Diagnostics Market Forecast, 2024-2034 (US$ Billion, AGR %)
Figure 113 MEA In Vitro Diagnostics Market Attractiveness Index
Figure 114 MEA In Vitro Diagnostics Market by Region, 2024, 2029 & 2034 (US$ Billion)
Figure 115 MEA In Vitro Diagnostics Market Forecast by Country, 2024-2034 (US$ Billion, AGR %)
Figure 116 MEA In Vitro Diagnostics Market Forecast by Product, 2024-2034 (US$ Billion, AGR %)
Figure 117 MEA In Vitro Diagnostics Market Forecast by Test, 2024-2034 (US$ Billion, AGR %)
Figure 118 MEA In Vitro Diagnostics Market Forecast by Application, 2024-2034 (US$ Billion, AGR %)
Figure 119 MEA In Vitro Diagnostics Market Forecast by End-users, 2024-2034 (US$ Billion, AGR %)
Figure 120 GCC In Vitro Diagnostics Market Forecast, 2024-2034 (US$ Billion, AGR %)
Figure 121 South Africa In Vitro Diagnostics Market Forecast, 2024-2034 (US$ Billion, AGR %)
Figure 122 Rest of MEA In Vitro Diagnostics Market Forecast, 2024-2034 (US$ Billion, AGR %)
Figure 123 QIAGEN: Net Revenue, 2021-2023 (US$ Million, AGR %)
Figure 124 QIAGEN: Regional Market Shares (%), 2023
Figure 125 QIAGEN: R&D, 2021-2023 (US$ Million, AGR %)
Figure 126 QIAGEN: Net Revenue, 2021-2023 (US$ Million, AGR %)
Figure 127 QIAGEN: Regional Market Shares (%), 2023
Figure 128 QIAGEN: R&D, 2021-2023 (US$ Million, AGR %)
Figure 129 BD: Net Revenue, 2021-2023 (US$ Million, AGR %)
Figure 130 BD: Regional Market Shares (%), 2023
Figure 131 BD: R&D, 2021-2023 (US$ Million, AGR %)
Figure 132 BioMérieux SA: Net Revenue, 2021-2023 (US$ Million, AGR %)
Figure 133 BioMérieux SA: Regional Market Shares (%), 2023
Figure 134 BioMérieux SA: R&D, 2021-2023 (US$ Million, AGR %)
Figure 135 F. Hoffmann-La Roche, Ltd.: Net Revenue, 2021-2023 (US$ Million, AGR %)
Figure 136 F. Hoffmann-La Roche, Ltd.: Regional Market Shares (%), 2023
Figure 137 F. Hoffmann-La Roche, Ltd.: R&D, 2021-2023 (US$ Million, AGR %)
Figure 138 Quidel: Net Revenue, 2021-2023 (US$ Million, AGR %)
Figure 139 Quidel: Regional Market Shares (%), 2023
Figure 140 Quidel: R&D, 2021-2023 (US$ Million, AGR %)
Figure 141 Ortho Corporation: Net Revenue, 2021-2023 (US$ Million, AGR %)
Figure 142 Ortho Corporation: Regional Market Shares (%), 2023
Figure 143 Ortho Corporation: R&D, 2021-2023 (US$ Million, AGR %)
Figure 144 Abbott: Net Revenue, 2021-2023 (US$ Million, AGR %)
Figure 145 Abbott: Regional Market Shares (%), 2023
Figure 146 Abbott: R&D, 2021-2023 (US$ Million, AGR %)
Figure 147 Agilent Technologies, Inc.: Net Revenue, 2021-2023 (US$ Million, AGR %)
Figure 148 Agilent Technologies, Inc.: Regional Market Shares (%), 2023
Figure 149 Agilent Technologies, Inc.: R&D, 2021-2023 (US$ Million, AGR %)
Figure 150 Thermofisher Scientific, Inc.: Net Revenue, 2021-2023 (US$ Million, AGR %)
Figure 151 Thermofisher Scientific, Inc.: Regional Market Shares (%), 2023
Figure 152 Thermofisher Scientific, Inc.: R&D, 2021-2023 (US$ Million, AGR %)
Figure 153 Siemens Healthineers AG: Net Revenue, 2021-2023 (US$ Million, AGR %)
Figure 154 Siemens Healthineers AG: Regional Market Shares (%), 2023
Figure 155 Siemens Healthineers AG: R&D, 2021-2023 (US$ Million, AGR %)
Figure 156 Bio-Rad Laboratories, Inc.: Net Revenue, 2021-2023 (US$ Million, AGR %)
Figure 157 Bio-Rad Laboratories, Inc.: Regional Market Shares (%), 2023
Figure 158 Bio-Rad Laboratories, Inc.: R&D, 2021-2023 (US$ Million, AGR %)
Figure 159 Danaher: Net Revenue, 2021-2023 (US$ Million, AGR %)
Figure 160 Danaher: Regional Market Shares (%), 2023
Figure 161 Danaher: R&D, 2021-2023 (US$ Million, AGR %)
Figure 162 Sysmex Corporation: Net Revenue, 2021-2023 (US$ Million, AGR %)
Figure 163 Sysmex Corporation: Regional Market Shares (%), 2023
Figure 164 Sysmex Corporation: R&D, 2021-2023 (US$ Million, AGR %)
Figure 165 Charles River Laboratories: Net Revenue, 2021-2023 (US$ Million, AGR %)
Figure 166 Charles River Laboratories: Regional Market Shares (%), 2023
Figure 167 Charles River Laboratories: R&D, 2021-2023 (US$ Million, AGR %)
Figure 168 Quest Diagnostics Incorporated: Net Revenue, 2021-2023 (US$ Million, AGR %)
Figure 169 Quest Diagnostics Incorporated: Regional Market Shares (%), 2023
Figure 170 Quest Diagnostics Incorporated: R&D, 2021-2023 (US$ Million, AGR %)
Figure 171 Illumina, Inc.: Net Revenue, 2021-2023 (US$ Million, AGR %)
Figure 172 Illumina, Inc.: Regional Market Shares (%), 2023
Figure 173 Illumina, Inc.: R&D, 2021-2023 (US$ Million, AGR %)
Figure 174 Hologic: Net Revenue, 2021-2023 (US$ Million, AGR %)
Figure 175 Hologic: Regional Market Shares (%), 2023
Figure 176 Hologic: R&D, 2021-2023 (US$ Million, AGR %)
Figure 177 Revvity: Net Revenue, 2021-2023 (US$ Million, AGR %)
Figure 178 Revvity: Regional Market Shares (%), 2023
Figure 179 Revvity: R&D, 2021-2023 (US$ Million, AGR %)
Figure 180 Exact Sciences: Net Revenue, 2021-2023 (US$ Million, AGR %)
Figure 181 Exact Sciences: Regional Market Shares (%), 2023
Figure 182 Exact Sciences: R&D, 2021-2023 (US$ Million, AGR %)
Figure 183 Company20: Net Revenue, 2021-2023 (US$ Million, AGR %)
Figure 184 Company20: Regional Market Shares (%), 2023
Figure 185 Company20: R&D, 2021-2023 (US$ Million, AGR %)

Companies Mentioned

  • Abbott
  • Agilent Technologies, Inc.
  • BD
  • Bio-Rad Laboratories, Inc.
  • BioM√©rieux SA
  • Charles River Laboratories
  • Danaher
  • Exact Sciences
  • F. Hoffmann-La Roche, Ltd.
  • Hologic
  • Illumina, Inc.
  • Ortho Corporation
  • QIAGEN
  • Quest Diagnostics Incorporated
  • Quidel
  • Revvity
  • Siemens Healthineers AG
  • Sysmex Corporation
  • Thermofisher Scientific, Inc.
  • ACON Laboratories, Inc.
  • Accelerate Diagnostics, Inc.
  • Adaltis S.r.l.
  • ANGSTROM Biotech
  • ARKRAY, Inc.
  • Boster Biological Technology
  • Caris Life Sciences
  • Cellabs
  • Chembio Diagnostics, Inc.
  • Creative Diagnostics
  • DEvyser
  • DIATEK Group
  • ElitTech
  • Enzo Biochem Inc.
  • Epitope Diagnostics, Inc.
  • Genetic Signatures
  • Genuine Biosystem
  • GENSPEED Biotech GmbH
  • Grifols, S.A.
  • J. Mitra & Co. Pvt. Ltd.
  • JSR Life Sciences, LLC
  • Maccura Biotechnology Co., Ltd.
  • Menarini Silicon Biosystems
  • Mdxhealth
  • Merck KGaA
  • Savyon Diagnostics
  • Seegene Inc.
  • SpeeDx Pty. Ltd.
  • Surmodics, Inc.
  • Trivitron Healthcare
  • Vela Diagnostics
  • ViraTeb
  • Werfen
  • Zellen Biotech LLP
  • American Association of Bioanalysts (AAB)
  • American Association for Clinical Chemistry (AACC)
  • American Association of Endocrinologists (AAE)
  • American Association of Medical Colleges (AAM)
  • Association of British HealthTech Industries (ABHI)
  • American Heart Association (AHA)
  • American Health Information Management Association (AHIMA)
  • American Medical Diagnostics Industry Association (AMDIS)
  • Association for Molecular Pathology (AMP)
  • American Medical Technology Society (AMTS)
  • American Society for Clinical Pathology (ASCP)
  • American Society of Echocardiography (ASE)
  • ASTM International
  • British Standards Institution (BSI)
  • Clinical Laboratory Management Association (CLMA)
  • Clinical and Laboratory Standards Institute (CLSI)
  • Canadian Medical Association (CMA)
  • Canadian Medical Laboratory Association (CMLA)
  • Computerized Physician Order Entry (CPOE)
  • Council of State and Territorial Epidemiologists (CSTE)
  • European Centre for Disease Prevention and Control (ECDC)
  • European Federation of Clinical Chemistry and Laboratory Medicine (EFLM)
  • European Hematology Association (EHA)
  • European Laboratory Network (ELN)
  • European Laboratory Safety Association (ELSA)
  • European Society of Cardiology (ESC)
  • European Society of Human Reproduction and Embryology (ESHRE)
  • European Union of Laboratory Medicine (EULIS)
  • Florida International Medical Expo (FIME)
  • Healthcare Information and Management Systems Society (HIMSS)
  • International Federation of Biomedical Laboratory Science (IFBLS)
  • International Federation of Clinical Chemistry and Laboratory Medicine (IFCC)
  • International Society for Biological and Environmental Repositories (ISBER)
  • Laboratory Developed Tests (LDT) Association
  • Laboratory of Government Chemists (LGC)
  • National Association of County and City Health Officials (NACCHO)
  • National Association of Chain Drug Stores (NACDS)
  • National Association of Community Health Centers (NACRC)
  • National Association of Testing Authorities (NAT)
  • National Coalition for Adult Immunization (NCA)
  • National Committee for Clinical Laboratory Standards (NCCLS)
  • National Cardiovascular Data Registry (NCDR)
  • National Community Pharmacists Association (NCPA)
  • National Committee for Quality Assurance (NCQA)
  • National Diagnostic Association (NDA)
  • National Healthcare Corporation (NHC)
  • National Health Service (NHS)
  • National Health Service Corps (NHSC)
  • National Institute on Aging (NIA)
  • National Institutes of Health (NIH)
  • National Medical Laboratory Association (NMLA)
  • National Safety Council (NSC)
  • National Society of Genetic Counselors (NSGC)
  • Professional Association of Medical Laboratory Scientists (PAML)
  • Pan American Health Organization (PAP)
  • Pathology & Clinical Laboratory Science (PCLS)
  • Public Health Genomics Foundation (PHG Foundation)
  • Precision Medicine Partnership Alliance (PMP)
  • Society of Biologics Organizations (SBO)
  • Society for Clinical Chemistry (SCC)
  • Society of Critical Care Medicine (SCCM)
  • Society for In Vitro Biology (SIB)
  • Society of Immunology and Cell Biology (SIC)
  • Society for Immunotherapy of Cancer (SIS)
  • Society for Laboratory Automation and Screening (SLA)
  • Society for Laboratory Automation and Screening (SLAS)
  • Society for Medical Laboratory Science (SMLA)
  • Society of Nuclear Medicine and Molecular Imaging (SNMMI)
  • Standards of Practice Association (SOP)
  • Value-Based Care Association (VBC)
  • World Association of Societies of Pathology and Laboratory Medicine (WAS)
  • World Health Organization (WHO)
  • World Laboratory Association of Biomedical Laboratories (WLAB)

Related Topics

Related Reports

In Vitro Diagnostics Market, Industry Trends and Global Forecasts to 2035: Distribution by Test Type, Type of Offering, Type of Technology, Therapeutic Area, End Users and Geographical Regions - Product Image

In Vitro Diagnostics Market, Industry Trends and Global Forecasts to 2035: Distribution by Test Type, Type of Offering, Type of Technology, Therapeutic Area, End Users and Geographical Regions

  • Report
  • 188 Pages
  • Global
From
U.S. In-Vitro Diagnostics Market - Focused Insights 2024-2029 - Product Image

U.S. In-Vitro Diagnostics Market - Focused Insights 2024-2029

  • Report
  • 115 Pages
  • United States
From
North America In-Vitro Diagnostics Market Forecast to 2030 - Regional Analysis - by Product & Services, Technology, Application, and End User - Product Image

North America In-Vitro Diagnostics Market Forecast to 2030 - Regional Analysis - by Product & Services, Technology, Application, and End User

  • Report
  • 112 Pages
  • North America
From
In-Vitro Diagnostics Market by Component, Technology, Specimen, Application, End User - Global Forecast 2025-2030 - Product Image

In-Vitro Diagnostics Market by Component, Technology, Specimen, Application, End User - Global Forecast 2025-2030

  • Report
  • 180 Pages
  • Global
From
Companion Diagnostics (CDx) Market Report 2024-2034 - Product Image

Companion Diagnostics (CDx) Market Report 2024-2034

  • Report
  • 307 Pages
  • Global
From
Copyright © 2002-2024 Research and Markets. All Rights Reserved.